Active Substance & Generic Molecule Directory

Lactobacillus Reuteri in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Lactobacillus Reuteri registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

12
Registered Brands
Availability in Malaysia:12 Supplements (MAL-N)
Showing 12 of 12 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL21126036NCRBIOGAIA PRODENTIS LOZENGES18.1 mg 800.0 mgHealth Supplement (MAL-N)Pharma Ace Sdn. Bhd.Compare →
MAL26086193NCJRH V-FLORACARE CAPSULE200 mg 500 mgHealth Supplement (MAL-N)Janipro (M) Sdn BhdCompare →
MAL18016118NLANG bragman PYLOMAX capsule100mg 400 mgHealth Supplement (MAL-N)OMEGA HEALTH PRODUCTS SDN BHDCompare →
MAL20172761NLANG bragman PYLORESS Powder100mg 1500mgHealth Supplement (MAL-N)OMEGA HEALTH PRODUCTS SDN BHDCompare →
MAL23126124NLANG bragman RESBECLEAR powder10 mg 2000 mgHealth Supplement (MAL-N)OMEGA HEALTH PRODUCTS SDN BHDCompare →
MAL24106093NMariflora-R Oral Drops4.1667 mg 0.2 mlHealth Supplement (MAL-N)REFORMS PHARMA SDN. BHD.Compare →
MAL24096092NNOVA PROBIOTIC DROPS0.50 mg 0.25 mlHealth Supplement (MAL-N)NOVA LABORATORIES SDN. BHD.Compare →
MAL24016048NCNuvanta Pylo-X Vegetable Capsule200 mg 500 mgHealth Supplement (MAL-N)MICROBIOME INTL (M) SDN. BHD.Compare →
MAL21106090NCPHARMORIX SYMFLORIZ-35 CAPSULE100 mg 480 mgHealth Supplement (MAL-N)PHARMORIX (M) SDN. BHD.Compare →
MAL17107058NCPYLOBALANCE Capsule200mg 500mgHealth Supplement (MAL-N)Y.S.P. INDUSTRIES (M) SDN. BHD.Compare →
MAL21096025NCPYLODAY Lactobacillus Reuteri 10 Billion CFU Capsules100.00 mg 230.00 mgHealth Supplement (MAL-N)Synercam (M) Sdn BhdCompare →
MAL20106051NV? ORT Lactobacillus reuteri + Vitamin C with Zinc Plus Powder20 mg 4200 mgHealth Supplement (MAL-N)JASE HEALTHCARE SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.